<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02104856</url>
  </required_header>
  <id_info>
    <org_study_id>E7086</org_study_id>
    <nct_id>NCT02104856</nct_id>
  </id_info>
  <brief_title>Bronchial Thermoplasty Global Registry</brief_title>
  <acronym>BT Registry</acronym>
  <official_title>Bronchial Thermoplasty (BT) Global Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this Registry is to collect real-world data on patients undergoing
      bronchial thermoplasty (BT) treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Registry is a prospective, open-label, single arm, observational registry to collect
      outcome data as well as clinical and demographic characteristics of patients undergoing BT
      treatment in the &quot;real world&quot; setting. Patients will be recruited at participating study
      centers that offer BT as a treatment option to patients with asthma who remain symptomatic
      despite taking standard of care maintenance medications.

      The Registry will be conducted at up to 80 sites globally and will enroll up to 500 patients.
      The treatment period is from the date of the first BT procedure until 6 weeks after the third
      (last) procedure (approximately 12 weeks). The post-treatment period starts at the date of
      the 6-week follow up visit after completion of the third (last) BT procedure for 2-years of
      follow-up.

      The primary endpoint will be the proportion of patients who experience severe asthma
      exacerbations at 1 and 2 years following BT treatment with the Alair System.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Proportion of patients who experience severe asthma exacerbations</measure>
    <time_frame>2 years</time_frame>
    <description>The primary endpoint will be the proportion of patients who experience severe asthma exacerbations at 1 and 2 years following BT treatment with the Alair System.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma Quality of Life Questionnaire (AQLQ) score</measure>
    <time_frame>2 years</time_frame>
    <description>Change from baseline in Asthma Quality of Life Questionnaire (AQLQ) scores will be summarized descriptively for Year 1 and Year 2 post-BT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Test (ACT) score</measure>
    <time_frame>2 years</time_frame>
    <description>Change from baseline in Asthma Control Test (ACT) scores will be summarized descriptively for Year 1 and Year 2 post-BT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency department visits for asthma symptoms</measure>
    <time_frame>2 years</time_frame>
    <description>Will be summarized both by the incidence (percentage of subjects reporting at least one event) and event rates (events/subject/year) for 1 and 2 Years post-BT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations for asthma symptoms</measure>
    <time_frame>2 years</time_frame>
    <description>Will be summarized both by the incidence (percentage of subjects reporting at least one event) and event rates (events/subject/year) for 1 and 2 Years post-BT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unscheduled office visits including urgent care visits for asthma symptoms.</measure>
    <time_frame>2 years</time_frame>
    <description>Will be summarized both by the incidence (percentage of subjects reporting at least one event) and event rates (events/subject/year) for 1 and 2 Years post-BT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre- and post-bronchodilator FEV1</measure>
    <time_frame>2 years</time_frame>
    <description>Pre- and post-bronchodilator FEV1 will be summarized for Year 1 and Year 2 post-BT treatment (% predicted and absolute value). Change from baseline will also be summarized.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Adverse Events</measure>
    <time_frame>2 years</time_frame>
    <description>Separated by treatment period and post-treatment period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung Volumes</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion Capacity</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma maintenance medication use (Long Acting Beta Agonists, steroids etc.)</measure>
    <time_frame>2 years</time_frame>
    <description>Collect asthma maintenance medications at all sites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction survey score</measure>
    <time_frame>2 years</time_frame>
    <description>Two question survey collected at 12 month and 24 month annual visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergic skin test or RAST (perennial, seasonal, mold)</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sputum eosinophils</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exhaled nitric oxide (eNO)</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Methacholine challenge (Methacholine PC20)</measure>
    <time_frame>2 years</time_frame>
    <description>Collected at sites where it is standard of care</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Alair System (Bronchial Thermoplasty)</arm_group_label>
    <description>Asthma patients undergoing Bronchial Thermoplasty treatment with commercially available Alair device as per Directions For Use.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alair System (Bronchial Thermoplasty)</intervention_name>
    <arm_group_label>Alair System (Bronchial Thermoplasty)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing BT according to labeled indications will be approached to
        participate in the Registry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is an adult aged 18 years or older and is scheduled to undergo BT treatment
             according to the Alair System DFU.

          2. Patient is able to read, understand, and sign a written Informed Consent to
             participate in the Registry and able to comply with the registry requirements.

        Exclusion Criteria:

        1. Patient has any medical condition that would make them inappropriate for BT treatment,
        in the Investigator's opinion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Niven, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wythenshawe Hospital - University of Manchester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfons Torrego, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundaci√≥ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felix Herth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thoraxklinik, University of Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Macquarie University Private Hospital</name>
      <address>
        <city>North Ryde</city>
        <state>New South Wales</state>
        <zip>2109</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4001</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Andrews War Memorial Hospital</name>
      <address>
        <city>Spring Hill</city>
        <state>Queensland</state>
        <zip>4000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Health</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <zip>3199</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John of God Geelong Hospital</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Tuberkulozy a Respiracnich Onemocneni</name>
      <address>
        <city>Prague</city>
        <zip>12802</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universit√§tsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>D-53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruhrlandklinik, Westdeutsches Lungenzentrum</name>
      <address>
        <city>Essen</city>
        <zip>45239</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik, University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93042</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Ospedali Riuniti</name>
      <address>
        <city>Ancona</city>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale di Mantova</name>
      <address>
        <city>Mantova</city>
        <zip>46100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aricispedale Santa Maria Nuova</name>
      <address>
        <city>Reggio nell Emilia</city>
        <zip>41223</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cape Town Groote Shuur Hospital</name>
      <address>
        <city>Cape Town</city>
        <zip>7925</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias I Puyol</name>
      <address>
        <city>Barcelona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Mara√±on</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gartnavel General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G12 OYN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2014</study_first_submitted>
  <study_first_submitted_qc>April 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2014</study_first_posted>
  <last_update_submitted>January 27, 2017</last_update_submitted>
  <last_update_submitted_qc>January 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Bronchial Thermoplasty</keyword>
  <keyword>Registry</keyword>
  <keyword>Device</keyword>
  <keyword>Alair</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

